[ELN.IR] Elan

Symbol: ELN.IR

- Says that FY revenue will be "close to $1.0B" v $1.04Be
- Encouraged by results in Bapineuzumab

Other headlines for [ELN.IR]

• ELN Today 11:41am
  Elan Corp PLC Morgan Stanley Initiates ELN with Overweight (timing uncertain)- price target €12
  
• ELN 8/25/2008 03:23pm
  Elan Corp PLC FDA issues update on Tysabri, continues to work on adjusted product labeling- comments again on the two cases of PML that were reported in July and the need to affirm to those taking Tysabri that the more...
  
• ELN 8/24/2008 10:12pm
  Elan Corp PLC Warburg Pincus plans to enter the bidding for Elan's drug delivery unit - Times
  
• ELN 8/22/2008 02:09am
  Elan Corp PLC KKR pulls out of bidding for Elan's drug delivery unit - Irish Independent
  
• ELN 8/12/2008 09:40am
  Elan Corp PLC Has reportedly received the first round of bids in hopes for sale of drug delivery unit at speculated value of $1.3-1.4B - Irish Times
  

Healthcare sector headlines

• BRL Today 12:19pm
  Barr Pharmaceuticals Inc Subsidiary receives approval for generic version of Razadyne tablets- Co. received final approval from the U.S. FDA to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne, 4 more...
  
• THR.BE Today 12:07pm
  ThromboGenics Reports H108 Rev €30.3M; Appoints Dr. Patrik De Haes CEO- As of June 30, 2008, ThromboGenics had €40.4M in cash and cash equivalents. - Co. expects to see an increase in its operating expenses in more...
  
• HITK Today 11:54am
  Hi-Tech Pharmacal Update: Files suit to confirm market exclusivity status regarding Dorzolamide and Timolol Ophthalmic Solution- Note: dorzolamide and timolol ophthalmic solution is the generic for Merck's Cosopt
  
• ELN Today 11:41am
  Elan Corp PLC Morgan Stanley Initiates ELN with Overweight (timing uncertain)- price target €12
  
• WX Today 09:39am
  Wuxi Pharmatech Inc ADR UPDATE: Merrill Lynch Resumed WX with Buy, price target: $23- pre-open